APA (7th ed.) Citation

Sachpekidis, C., Kopp-Schneider, A., Pan, L., Papamichail, D., Haberkorn, U., Hassel, J. C., & Dimitrakopoulou-Strauss, A. (2021). Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma. European journal of nuclear medicine and molecular imaging, 48(6), . https://doi.org/10.1007/s00259-020-05137-7

Chicago Style (17th ed.) Citation

Sachpekidis, Christos, Annette Kopp-Schneider, Leyun Pan, Dimitrios Papamichail, Uwe Haberkorn, Jessica C. Hassel, and Antonia Dimitrakopoulou-Strauss. "Interim (18F)FDG PET/CT Can Predict Response to Anti-PD-1 Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine and Molecular Imaging 48, no. 6 (2021). https://doi.org/10.1007/s00259-020-05137-7.

MLA (9th ed.) Citation

Sachpekidis, Christos, et al. "Interim (18F)FDG PET/CT Can Predict Response to Anti-PD-1 Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 6, 2021, https://doi.org/10.1007/s00259-020-05137-7.